MarketLens
Sign Up

What Does the FDA's NDA Acceptance Mean for Mineralys Therapeutics

5 months ago
SHARE THIS ON:

What Does the FDA's NDA Acceptance Mean for Mineralys Therapeutics

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•1 months ago

Mineralys: Why I'm Making Stock A Buy Ahead Of Hypertension Approval Decision

Mineralys Therapeutics was upgraded to Buy ahead of a December FDA decision on lorundrostat. The drug shows competitive efficacy and safety, with blockbuster revenue potential and possible label expan...
Stock News•1 months ago

Clene Eyes Q4 NDA for ALS Drug After FDA-Requested Biomarker Analyses

Clene plans to submit a Q4 NDA for CNM-Au8 in ALS after completing FDA-requested biomarker analyses, CEO Rob Etherington said. The filing seeks accelerated approval and could determine the drug's U.S....
Stock News•1 months ago

Cardiol Therapeutics Advances CardiolRx in Pivotal Phase III Pericarditis Trial

Cardiol Therapeutics is advancing CardiolRx in a pivotal Phase III trial for recurrent pericarditis, a key step toward a potential new drug application. The program's outcome could determine the drug'...

Breaking News

View All →

Top Headlines

View More →
Stock News•1 hour ago

Apple (AAPL) Advances While Market Declines: Some Information for Investors

Stock News•1 hour ago

Nvidia-Backed Firmus Scraps Australian IPO, Citing Market Conditions

Stock News•1 hour ago

History Says Every S&P 500 Bull Market That Reached Its 4th Birthday Kept Going

Stock News•2 hours ago

Pilot and Tesla Open First Megacharger Site, Announce Three Additional Locations Opening Soon

Stock News•2 hours ago

Why Meta is winning the micro drama wars